Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has appointed Tadahiro Matsumura as Country Leader, Japan.
Catalent has been operating in Japan for 40 years and is to open a dedicated laboratory at its Kakegawa site in September, which will provide proof-of-concept support and feasibility studies for the company's Zydis Orally Dispersible Tablet (ODT) technology and will also expand manufacturing capacity for its OptiGel Micro softgel technology.
Based in Catalent’s Tokyo office, Matsumura will have responsibility for driving growth through business development activities in Japan and the surrounding region. He has more than 30 years of experience after starting his career in 1983 at Procter & Gamble Healthcare as a product development supervisor, and also held marketing positions of increasing responsibility in the Japan business units of Wella. He joined Johnson & Johnson in 1994, where most recently he was vice president of sales for vision care.
Matsumura has a degree in biological chemistry.
